BSEResult1d ago · 14 Aug 2026, 07:26 pm

Quarterly Results June 30, 2026

Natural Biocon (India) Ltd · 543207

✦ AI SummaryResults

Natural Biocon (India) Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 8785 lakhs and profit before tax at Rs. 16 lakhs. The company has also approved the appointment of new statutory auditors and the resignation of the previous auditors.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natural Biocon (India) Ltd - 543207 - Quarterly Results June 30, 2026

Attachments (1)

📄

dfe98300-fa74-40d1-a6d5-fe74b9ebb03f.pdf

pdf

Download →
View document text
BNIAOTUCROANL miveo & www.naturalbiocon.com Regd. Office : o soo o BN info@naturalbiocon.com @) A-1007.Sankalp iconic Tower. A g= Opp, Vikram Nagar,Iscon Temple Cross Road, S.G.Highway, Ahmedabad 380054,Gujarat,India oSt No - 2anAacNGss1KizD || GIN:L24299GI1992PLC018210 August 14, 2026 To, To, The General Manager Corporation The Secretary Relationship Department BSE Limited The Calcutta Stock Exchange Ltd. P.] Towers, Dalal Street 7, Lyons Range Mumbai - 400001 Kolkata - 700 001 Script Code: 543207 Scrip Code: 24151 Dear Sir/Madam, Sub: Outcome of the meeting of the Board of Directors held on Friday, August 14, 2026. Ref: Regulation 30 & 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation, 2015. ‘With reference to above subject and in compliance with Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Directors held on today i.e., Friday, August 14, 2026 at 06:30 p.m. and concluded on 07:10 p.m. inter alia considered and approved the following: 1) Un-Audited Financial Results (UFR) for the quarter ended June 30, 2026, along with the Statutory Auditors’ Limited Review Report. 2) Considered and approved the appointment of M/s Nirav S Shah & Co as the Statutory Auditors oft he Company with effect from 1% August 2026. 3) Approved the resignation of M/s Mayur Shah & Associates as the Statutory Auditors of the Company with effect from 31° July 2026. 4) Reviewed the other businesses of the company. Please take the same on record. BNIAOTUCROANL @ www.naturalbiocon.com Regd. Office : ©79 46005570 B info@naturalbiocon.com ) A-1007.Sankalp iconic Tower. Opp, Vikram Nagar,Iscon Temple Cross Road, S.G.Highway, Ahmedabad 380054,Gujarat,India oSt No - 2anAacNGss1KizD || GIN:L24299GI1992PLC018210 Thanking You Yours faithfully, For Natural Biocon (India) Limited Pom D (P /"'\(//'%> Arunkumar Prajapati Managing Director DIN: 08281232 Encl. As Above NATURAL BIOCON (INDIA) LIMITED N - 124209GJ1992PLC018210 Reg off: 1007, Sankalp Iconic, Opp. Vikram Nagar, Iscon Temple Cross Road, S. G. Highway,Ahmedabad, Ahmedabad, Gujarat, India, 380054 E-Mail: naturalbiocon@gmail.com STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED JUNE 30, 2026 (Amtin Rs. In Lakhs) ‘Quarter ended Vear Ended 3006.2026 31032026 30062025 3103.2026 31032025 SLNO PARTICULARS (Unaudited) (Audited) (Audited) (Audited) (Audited) i [Revenue from Operations B 8785 16657 25441 83451 [T [OtherTcome B 012 - 012 - @ [Total Income(i-1 - 8797 16657 25454 834.81 [V [EXPENSES [Cost of materials consumed - - - - - [Purchases of Stock i wade - 20089 20089 739.96 [Changes i Taventones of Tiished g00ds, Stock-i-uade Jand work in progress 7053 (5388) 1665 ©56) [Exployee benefits expense B 1118 225 1747 3067 [Finance Costs B - - - - [Depreciation and amortization expenses 010 009 006 034 006 [Other expenses 106 1551 339 519 5872 [Total Expenses 116 9731 15271 25854 828,85 [V [Profit/os) before exceptional items and tax(-IV) .16) ©39) 1386 @00) 596 [V [Exceptional tems - - - VI [Profit/osy) before tax(v-vD) 16) ©39) 1386 @00) 596 [VIT[Tax Expense (D) Curent Tax - - - - 150 [ Deferred Tax B B B B - [Profit/(Loss) for the period from continuing operatons( x vovim 16) ©34) 1386 “00) 446 [X[Profit(Loss) fom discontinued operations - - - - - [XI [T ax Expense of discontinued operations B B B B B Profit(loss)from Discontmed operations( After Ta) (- XTI [Profit/oss) for the period (X-XID) 16) ©39) 1386 @00) 446 X1V [Other Comprehensive Tncome - - - - Total Comprehensive Income for fhe period (XIFFXIV) [ Comprising Profit (Loss) and Other Comprehensive [xv_|Income for the period] 16) ©34) 1386 “00) 446 [xxv1 _|Paid up Equity Share Capital (Face value of Rs 10/- each) 2578.28 257828 2578.28 257828 257828 [Reserves exchuding revaluafion reserves as per balance sheef Vi |of previous years - - - - - Eamings per Equity Share (for contiming operaBom(Not [xvi|anmaised) (1 Basic (0.00) ©00%) 005 ©0) 002 [ Diuted (0.00) (0.0%) 005 ©00) 002 3V _|Eamings per Equity Share (for discontimed operation) (D) Basic - - - - - | Diuted - - - - - Eamings per Equity Share (for contiming & disconimed [ |operaton) (1) Basic (0.00) 0.0%) 005 ) [ | Dituted (0.00) (0.0%) 005 ©00) [ 1 The above Standalone audited financial results of the Company for the quarter ended Juae 30th have been reviewed and have been approved and taken on fecord by the Board of Directors i its me eting held on 14th August, 2026. 2. The Company has single reportable segment as defined in Indian Accounting Standard 108 and therefore segment reporting is not applicable for the company. 3 The above Standalone Financial results have been are prepaed as per applicable IND Accounting standards notified by Ministry of Corporate Affairs. 4 Figures of the previous period have been regrouped wherever necessary to the current year classification. 5 EPS is calculated in accordance with IND AS issued by ICAL For Natural Biocon (India) Limited Arunkumar Prajapati Managing Director [Piace: Abmedabad [Date: 14/08/2026 DIN: 08281232 Nirav S. Shah & Co. PN Nirav Shah Chartered Accountants B.com, LLB, FCA Office Add : 401, Abhishree Avenue, Opp. Hanuman Temple, Besides Shakti Electronics, Nehrunagar-Ambawadi, Ahmedabad - 380 015. M. No. 98256 09734 Email : incometax@caniravshah.com BOARD OF DIRECTORS, NATURAL BIOCON (INDIA) LIMITED AHMEDABAD LIMITED REVIEW REPORT "We have reviewed the accompanying statement of unaudited financial results of M/s. NATURAL BIOCON (INDIA) LIMITED for the period ended 30.06.2026. This statement is the responsibility of the Company’s management and has been approved by the Board of Directors. A review of interim financial information consists principally of applying analytical procedures for financial data and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the generally accepted auditing standards, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion. Based on our review conducted as above, nothing has come to our notice that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with Accounting Standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement" Date: 14.08.2026 Name of CA : Nirav Shah g Place: Ahmedabad FirmName : Nirav S. Shah Designation : Proprietor Membership No: 133345 FRN : o 130244w UDIN : 26133345TUMQFU3766